Abstract
In a multicenter, randomized, invesgtigator-blind, parallel study, 398 patients were dispensed topical butoconazole nitrate 2% cream for 3 days (n = 199) or miconazole nitrate 2% cream for 7 days (n = 199) for vaginal use. Efficacy analyses included 254 patients with culture-confirmed Candida (119 butoconazole and 135 miconazole users). Of the 398 patients issued study medication, 9 were lost to follow-up. Therefore, safety analyses included 389 patients (197 butoconazole and 192 miconazole users). Evaluations upon admission and approximately 8 and 30 days post-treatment included Candida cultures, potassium hydroxide (KOH) wet mounts, and vulvovaginal examinations, with rating of vulvovaginal signs and symptoms using a 4-point scale. Rates of clinical cure (based on sign/symptom scores), microbiologic cure (based on cultures and wet mounts), and therapeutic cure (both clinical and microbiologic cures) were assessed and were to be similar between the regimens. Therapeutic cure rates were 57.8% and 61.4% for butoconazole and miconazole, respectively. Three-day butoconazole treatment was as safe and effective as 7-day miconazole therapy in treating vulvovaginal candidiasis.
Full Text
The Full Text of this article is available as a PDF (540.7 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Adamson G. D. Three-day treatment of vulvovaginal candidiasis. Am J Obstet Gynecol. 1988 Apr;158(4):1002–1005. doi: 10.1016/0002-9378(88)90114-7. [DOI] [PubMed] [Google Scholar]
- Hunt L. M., Jordan B., Irwin S., Browner C. H. Compliance and the patient's perspective: controlling symptoms in everyday life. Cult Med Psychiatry. 1989 Sep;13(3):315–334. doi: 10.1007/BF00054341. [DOI] [PubMed] [Google Scholar]
- Kaufman R. H., Henzl M. R., Brown D., Jr, Horner D. S., Krauss R. H., Mehlisch D. R., Moore D. E., Prentice R. L. Comparison of three-day butoconazole treatment with seven-day miconazole treatment for vulvovaginal candidiasis. J Reprod Med. 1989 Jul;34(7):479–483. [PubMed] [Google Scholar]
- Kuritz S. J., Landis J. R., Koch G. G. A general overview of Mantel-Haenszel methods: applications and recent developments. Annu Rev Public Health. 1988;9:123–160. doi: 10.1146/annurev.pu.09.050188.001011. [DOI] [PubMed] [Google Scholar]
- Lynch M. E., Sobel J. D. Comparative in vitro activity of antimycotic agents against pathogenic vaginal yeast isolates. J Med Vet Mycol. 1994;32(4):267–274. [PubMed] [Google Scholar]
- Nixon S. A. Vulvovaginitis: the role of patient compliance in treatment success. Am J Obstet Gynecol. 1991 Oct;165(4 Pt 2):1207–1209. doi: 10.1016/s0002-9378(12)90728-0. [DOI] [PubMed] [Google Scholar]
- Uesaka H. Test for interaction between treatment and stratum with ordinal responses. Biometrics. 1993 Mar;49(1):123–129. [PubMed] [Google Scholar]